Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human PTH Antibodies:
anti-Rat (Rattus) PTH Antibodies:
anti-Mouse (Murine) PTH Antibodies:
Go to our pre-filtered search.
Human Monoclonal PTH Primary Antibody for IHC (fro), IHC (p) - ABIN2476062
Uzych: Hawaii and the AIDS epidemic. in Hawaii medical journal 1990
Show all 4 Pubmed References
Human Monoclonal PTH Primary Antibody for ELISA, WB - ABIN966922
French, Hamilton, Mattano, Sather, Devidas, Nachman, Relling: A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. in Blood 2008
Show all 3 Pubmed References
Human Monoclonal PTH Primary Antibody for ELISA, WB - ABIN1724741
Koshizuka, Ogata, Shiraki, Hosoi, Seichi, Takeshita, Nakamura, Kawaguchi: Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women. in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2006
Show all 2 Pubmed References
Human Monoclonal PTH Primary Antibody for ELISA, ICC - ABIN260228
Koh, Hogue, Sosa: A Novel Ex Vivo Method for Visualizing Live-Cell Calcium Response Behavior in Intact Human Tumors. in PLoS ONE 2016
PTH levels are significantly higher in untreated sustained hypertension patients than white-coat hypertension patients and normotensive subjects.
results revealed that PTH treatment on HCs (show HLCS Antibodies), either continuous or pulsatile, does not exhibit any positive effect, and indicates that exogenous PTH administration after fracture has no effect on HCs (show HLCS Antibodies). PTH may not have a positive effect at the fracture site during the early stage of fracture healing in which haematoma formation occurs.
Pre-incubation of muscle fibers or myotubes with physiological concentrations of PTH, concentration-dependently reduced uptake of labelled 25-hydroxyvitamin D3.
Baseline PTH level was not associated with changes in frailty status in men.
Elevated PTH induces the transition of endothelial cells to chondrogenic cells via endothelial-mesenchymal transition, possibly mediated by the nuclear translocation of beta-catenin (show CTNNB1 Antibodies).
Cys (show DNAJC5 Antibodies) mutation at the 25th residue of hPTH(1-34) may result in a high bone mass phenotype.
Common genetic variants located near genes involved in vitamin D metabolism and calcium and renal phosphate transport associated with differences in circulating parathyroid hormone concentrations
PTH pretreatment prevented TGF-beta1 (show TGFB1 Antibodies) and high glucose-induced Smad2 (show SMAD2 Antibodies)/3 phosphorylation and consequent upregulation of fibronectin (show FN1 Antibodies) and type IV collagen (show COL4 Antibodies) within 4 h.
FGFR1c and PTHR signaling pathways converge on NHERF1 to inhibit PTH- and FGF23-sensitive phosphate transport and down-regulate NPT2A.
In patients receiving dual antiplatelet therapy for coronary artery disease, higher PTH levels are associated with an increased ADP-mediated platelet reactivity and suboptimal response to clopidogrel.
These data highlight the ability of PTH to phosphorylate beta-catenin (show CTNNB1 Antibodies) directly via PKA.
These data suggest that prostaglandin E2 acting via EP4R (show PTGER4 Antibodies) on bone marrow macrophages committed to the osteoblast cell lineage, stimulated secretion of a factor or factors that acted to suppress PTH-stimulated osteoblast differentiation.
These results suggest that in vivo PTH treatment increased in vitro osteoclastogenesis and resorption without altering the number of osteoclast precursors.
Osteoblast 2-deoxyglucose uptake and glycogen (show GYS2 Antibodies) synthesis were increased after exposure to low concentrations (0.1 nmol/l and above) of PTH.
Parathyroid hormone stimulated growth and decreased Col-X deposition via phosphotidylinositol-3,4,5 triphosphate kinase and mitogen activating protein kinase pathways in avian sterna.
likely involvement of the Sp family in regulating PTH gene expression through interactions with an Sp1 (show SP1 Antibodies) DNA element in the hormone's promoter.
alternative cis (show CISH Antibodies)-acting protein-binding elements may determine the regulation of PTH mRNA stability in response to changes in serum calcium and phosphate
a possible role for the Wnt (show WNT2 Antibodies) signaling pathway in PTH actions in bone
Data suggest that calcium-mediated destabilization of parathyroid hormone mRNA requires gene transcription and involves increases in cytosolic Ca.
findings identify p38alpha (show MAPK14 Antibodies) MAPK (show MAPK1 Antibodies) as a key component of PTH signaling in osteoblast lineage cells and highlight its requirement in iPTH osteoanabolic activity
FGF23 (show FGF23 Antibodies) may be an important modulator of PTH signaling in bone and kidney.
These findings suggest that trabecular bone formation can occur independently of the CaSR (show CASR Antibodies), and that the CaSR (show CASR Antibodies) plays a collaborative role in the PTH anabolic effects on bone.
Mmp13 (show MMP13 Antibodies) is selectively regulated of by 1,25-Dihydroxyvitamin D3, PTH, and Osterix (show SP7 Antibodies) through distal enhancers.
PTHrP (show PTHLH Antibodies) and PTH mediate wasting through a common mechanism involving PTHR (show PTH1R Antibodies).
Usp2 (show USP2 Antibodies) is required for the PTH1-34-induced proliferation of osteoblasts
These results highlight the role of distal enhancers in the regulation of RANKL (show TNFSF11 Antibodies) expression by PTH and perhaps 1,25(OH)2D3 and suggest that the RL-D2 and RL-D5 enhancers contribute in either an additive or synergistic manner to regulate bone remodeling.
These results indicate that PTH-mediated inhibition of renal phosphate transport involves phosphorylation of S77 of the NHERF-1 PDZ I domain and the dissociation of NHERF-1/Npt2a complexes.
It was concluded that endogenously secreted PTH and GHR (show GHR Antibodies) signaling in bone are necessary to establish radial bone growth and optimize mineral acquisition during growth.
findings suggest that XLalphas (show GNAS Antibodies) enhances Gq/11 signaling to mediate the renal actions of PTH during early postnatal development.
The protein encoded by this gene is a hormone secreted by parathyroid cells. This hormone elevates blood Ca2+ level by dissolving the salts in bone and preventing their renal excretion. Defects in this gene are a cause of familial isolated hypoparathyroidism (FIH).
, parathyroid hormone 1
, preproparathyroid hormone
, hypothalamic parathyroid hormone
, thyroid hormone
, probable peptidyl-tRNA hydrolase